HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit.

AbstractBACKGROUND AND PURPOSE:
The BEST-MSU study (Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit) is a comparative effectiveness trial in patients randomized to mobile stroke unit or standard management. A substudy tested interrater agreement for tissue-type plasminogen activator eligibility between a telemedicine vascular neurologist and onboard vascular neurologist.
METHODS:
On scene, both the telemedicine vascular neurologist and onboard vascular neurologist independently evaluated the patient, documenting their tissue-type plasminogen activator treatment decision, National Institutes of Health Stroke Scale score, and computed tomographic interpretation. Agreement was determined using Cohen κ statistic. Telemedicine-related technical failures that impeded remote assessment were recorded.
RESULTS:
Simultaneous and independent telemedicine vascular neurologist and onboard vascular neurologist assessment was attempted in 174 patients. In 4 patients (2%), the telemedicine vascular neurologist could not make a decision because of technical problems. The telemedicine vascular neurologist agreed with the onboard vascular neurologist on 88% of evaluations (κ=0.73).
CONCLUSIONS:
Remote telemedicine vascular neurologist assessment is reliable and accurate, supporting either telemedicine vascular neurologist or onboard vascular neurologist assessment on our mobile stroke unit.
CLINICAL TRIAL REGISTRATION:
URL: http://www.clinicaltrials.gov. Unique identifier: NCT02190500.
AuthorsTzu-Ching Wu, Stephanie A Parker, Amanda Jagolino, Jose-Miguel Yamal, Ritvij Bowry, Abraham Thomas, Amy Yu, James C Grotta
JournalStroke (Stroke) Vol. 48 Issue 2 Pg. 493-496 (02 2017) ISSN: 1524-4628 [Electronic] United States
PMID28082671 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Copyright© 2017 American Heart Association, Inc.
Chemical References
  • Tissue Plasminogen Activator
Topics
  • Aged
  • Aged, 80 and over
  • Emergency Medical Services (methods, trends)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mobile Health Units (trends)
  • Neurologists (trends)
  • Pilot Projects
  • Stroke (diagnostic imaging, therapy)
  • Telemedicine (methods, trends)
  • Tissue Plasminogen Activator (administration & dosage)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: